Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Podcasts

Identifying the Benefits of Rapid At-Home Diagnostic Testing and How These Can Communicate With PCPs, Infectious Disease Professionals

10/25/2020

php logoRon Chiarello, PhD, CEO, Alveo Technologies, discusses a recent collaboration the company began with Janssen—where together they are working to improve and expand an at-home self-testing platform for viral infectious diseases—and explains why rapid diagnostics are a low-cost and essential option to flattening curves and reducing the spread of diseases like COVID-19.  

Advertisement

Advertisement

Advertisement

What's Trending?

Department
Optimal Response to Natalizumab in MS Patients
06/19/2012

Eileen Koutnik-FotopoulosÔªø

Eileen Koutnik-FotopoulosÔªø
Results from a small study found that inhibition of intrathecal antibody synthesis is associated with a complete therapeutic response to natalizumab in patients with aggressive multiple sclerosis (MS). Treatment with natalizumab decreased the...
Results from a small study found that inhibition of intrathecal antibody synthesis is associated with a complete therapeutic response to natalizumab in patients with aggressive multiple sclerosis (MS). Treatment with natalizumab decreased the...
Results from a small study found...
06/19/2012
First Report Managed Care
News
IV Opioid Solution Recalled
12/27/2016
The US Food and Drug Administration has recalled a strong opioid used to manage severe pain after sterility problems were made evident to the manufacturer. 
The US Food and Drug Administration has recalled a strong opioid used to manage severe pain after sterility problems were made evident to the manufacturer. 
The US Food and Drug...
12/27/2016
Pharmacy Learning Network
News
Antibiotic Development May Not be Bad Business for Drugmakers
12/26/2013
Drug companies have tapered the development of new antibacterials amid uncertainty about their profit potential, but a look at the history of these drugs shows they sell well in most cases, researchers say.
Drug companies have tapered the development of new antibacterials amid uncertainty about their profit potential, but a look at the history of these drugs shows they sell well in most cases, researchers say.
Drug companies have tapered the...
12/26/2013
Pharmacy Learning Network
Troubles With Drug Pricing Transparency
07/18/2019

Mary Beth Nierengarten

Mary Beth Nierengarten
Experts discuss the complications of drug pricing transparency, focusing on the rule requiring drug manufacturers to disclose list prices in TV advertisements, which has since been blocked by a federal judge.
Experts discuss the complications of drug pricing transparency, focusing on the rule requiring drug manufacturers to disclose list prices in TV advertisements, which has since been blocked by a federal judge.
Experts discuss the...
07/18/2019
First Report Managed Care
News
Horizon Blue Cross Must Turn Over Data on Narrow Network Plans
04/12/2018
A New Jersey judge ruled that Horizon Blue Cross Blue Shield must make a consulting report that led to the development of its narrow network OMNIA plans available to the public.
A New Jersey judge ruled that Horizon Blue Cross Blue Shield must make a consulting report that led to the development of its narrow network OMNIA plans available to the public.
A New Jersey judge ruled that...
04/12/2018
First Report Managed Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement